Product image of Mercilon 28 (Desogestrel, Ethinylestradiol | Lactose Monohydrate) supplied by GNH India

Mercilon 28

Active Ingredient:
Desogestrel, Ethinylestradiol | Lactose Monohydrate
Origin:
EU

Mercilon 28 (Desogestrel, Ethinylestradiol | Lactose Monohydrate)

Desogestrel and Ethinylestradiol, the active ingredients in Mercilon 28, are a combined oral contraceptive presented as a 150 µg/30 µg tablet for oral use. It prevents pregnancy in women of reproductive age.
GNH India supplies Mercilon 28 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

N.V. Organon

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mercilon 28 is a combined hormonal contraceptive used within the family planning and menstrual regulation pathway.

  • Contraception: prevents pregnancy in women of reproductive age by inhibiting ovulation.
  • Menstrual cycle regulation: helps achieve more predictable monthly periods.
  • Dysmenorrhea management: reduces menstrual pain associated with ovulatory cycles.

How It Works

  • Desogestrel and ethinylestradiol act together to suppress the hypothalamic‑pituitary‑gonadal axis, inhibiting the mid‑cycle surge of luteinising hormone (LH) and follicle‑stimulating hormone (FSH). This prevents follicular development and ovulation. The estrogen component stabilises the endometrium, while both hormones thicken cervical mucus, creating a hostile environment for sperm penetration.

Side Effects

Common Side Effects

  • Nausea: mild to moderate stomach upset, especially during the first cycles.
  • Breast tenderness: temporary swelling or discomfort of the breasts.
  • Headache: mild to moderate tension‑type headaches.
  • Spotting or breakthrough bleeding: irregular light bleeding between periods.
  • Mood changes: mild fluctuations in mood or irritability.

Serious or Rare Side Effects

  • Venous thromboembolism: deep vein thrombosis or pulmonary embolism, requiring immediate medical attention.
  • Arterial thrombosis: stroke or myocardial infarction, especially in high‑risk individuals.
  • Severe hypertension: sudden increase in blood pressure that may lead to organ damage.
  • Hepatic adenoma: rare benign liver tumor.
  • Anaphylaxis: severe allergic reaction with rash, swelling, and breathing difficulty.

Precautions & Warnings

Before prescribing Mercilon 28, clinicians should evaluate individual risk factors and counsel patients on safe use.

  • Assess thrombotic risk: avoid in women with a history of clotting disorders or recent surgery.
  • Screen for hypertension: monitor blood pressure regularly during therapy.
  • Avoid smoking: especially in women over 35 years of age.
  • Evaluate liver function: contraindicated in severe hepatic impairment.
  • Pregnancy category X: do not use during pregnancy; advise effective contraception.
  • Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Avoid Interactions

Mercilon 28 may interact with other medicines that affect hormone metabolism or clotting risk.

Major Interactions (Avoid)

  • Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): markedly reduce contraceptive efficacy.
  • Rifampin: decreases plasma hormone levels, increasing risk of unintended pregnancy.
  • St. John's wort: may lower contraceptive effectiveness.

Moderate Interactions (Monitor Closely)

  • Antibiotics such as tetracycline: may slightly diminish hormonal protection.
  • Antifungals (e.g., fluconazole): can increase estrogen levels, raising side‑effect potential.
  • Selective serotonin reuptake inhibitors (SSRIs): may increase bleeding tendency when combined with hormonal therapy.

Frequently Asked Questions

Mercilon 28 is a combined oral contraceptive containing desogestrel and ethinylestradiol. It is prescribed to prevent pregnancy in women of reproductive age and can also help regulate menstrual cycles and reduce menstrual pain.

Desogestrel is a progestin that suppresses the release of luteinising hormone (LH) and follicle‑stimulating hormone (FSH) from the pituitary gland, thereby preventing ovulation. Together with ethinylestradiol, it also thickens cervical mucus and alters the endometrium to hinder sperm penetration and implantation.

The dosing regimen for Mercilon 28 is determined by the prescribing healthcare professional. Typically, it is taken as one tablet daily for 21 days followed by a 7‑day pill‑free interval, but the exact schedule should be confirmed with the prescriber.

Mercilon 28 is classified as pregnancy category X, meaning it must not be used during pregnancy because it can cause fetal harm. It is generally not recommended while breastfeeding unless the benefits outweigh the risks, and a healthcare provider should be consulted.

To order Mercilon 28, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Mercilon 28 contains a low‑dose progestin (desogestrel) and a standard dose of ethinylestradiol, offering a favorable bleeding profile and effective contraception. Compared with older formulations that use higher estrogen doses, Mercilon 28 may have a lower risk of estrogen‑related side effects while maintaining comparable contraceptive efficacy.

Mercilon 28 tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original blister pack, protect from moisture and direct sunlight, and keep out of reach of children.

Mercilon 28 is taken orally, usually with water, once each day at the same time. It is important to follow the prescribed schedule without missing doses to maintain contraceptive effectiveness.

The most serious risks include venous or arterial thromboembolism (blood clots), severe hypertension, hepatic adenoma, and rare allergic reactions such as anaphylaxis. Women with a history of clotting disorders, smoking, or certain cardiovascular conditions should discuss these risks with their healthcare provider.

Mercilon 28 is contraindicated in women who are pregnant, have a known or suspected thromboembolic disorder, have uncontrolled hypertension, severe liver disease, or are smokers over 35 years of age. It should also be avoided in individuals with known hypersensitivity to desogestrel, ethinylestradiol, or any tablet excipients.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.